liver-cancer

Documents about liver-cancer

• Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer#898562ClinicalTrials.gov
• Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease#862059ClinicalTrials.gov
• Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT#907668ClinicalTrials.gov
• Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer#966989ClinicalTrials.gov
• VALIDATION OF THE VIBe INTRAOPERATIVE BLEEDING SCALE IN LIVER SURGERY#868260ClinicalTrials.gov
• Streamlining Radioembolization for CCC and Metastatic Liver Cancer#860355ClinicalTrials.gov
• Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)#830363ClinicalTrials.gov
• Open Label Trial of Immunotherapy for Advanced Liver Cancer#350019ClinicalTrials.gov
• Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases#918298ClinicalTrials.gov
• Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation#843553ClinicalTrials.gov
• Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer#1032211ClinicalTrials.gov
• PET/CT-Assessment of Liver Tumor Ablation#842018ClinicalTrials.gov
• Exploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach（Radiogenomics-Liver）#873855ClinicalTrials.gov
• Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab#889919ClinicalTrials.gov
• Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer#981965ClinicalTrials.gov
• Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease#801109ClinicalTrials.gov
• Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease#1032192ClinicalTrials.gov
• Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy#158206ClinicalTrials.gov
• Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)#300273ClinicalTrials.gov
• Colorectal Cancer, Liver Metastases and Biotherapies#364055HAL (France)
• HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver#994609ClinicalTrials.gov
• C-VISA BikDD: Liposome in Advanced Pancreatic Cancer#854051ClinicalTrials.gov
• Functional Liver After SBRT#810788ClinicalTrials.gov
• Major Hepatectomy and Vascular Clamping#836670ClinicalTrials.gov
• A First in Human Study of PLT012 in Participants With Solid Tumor Cancers#836016ClinicalTrials.gov
• Artificial Intelligence Diagnosis of Different Histopathological Growth Patterns of Colorectal Cancer Liver Metastasis#806785ClinicalTrials.gov
• Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy#863051ClinicalTrials.gov
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer#864281ClinicalTrials.gov
• Low-dose Y90 Treatment Planning for HCC#908143ClinicalTrials.gov
• Clinical Characteristics of Primary Liver Cancer#916759ClinicalTrials.gov
• Cancer cells produce liver metastasis via gap formation in sinusoidal endothelial cells through proinflammatory paracrine mechanisms#329702Dipòsit Digital de la Universitat de Barcelona
• Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation#829131ClinicalTrials.gov
• Prognostic Factors and Oncological Outcomes in Laparoscopic Liver Resection for CRLM#828386ClinicalTrials.gov
• PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES#834702ClinicalTrials.gov
• A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib#901535ClinicalTrials.gov
• Novel MRE Technique to Assess a Risk Factor for Liver Cancer#888626ClinicalTrials.gov
• Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy#981677ClinicalTrials.gov
• SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases#174873ClinicalTrials.gov
• Prospective Observational Cohort Study#858514ClinicalTrials.gov
• Displacement Distance and Stabilization Time for Liver Fiducial Marker#880079ClinicalTrials.gov
• Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter#907167ClinicalTrials.gov
• Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases#174883ClinicalTrials.gov
• The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer#860758ClinicalTrials.gov
• Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)#870866ClinicalTrials.gov
• Prospective Clinical Study of Intraoperative Assessment of Resection Margin of Colo-Rectal Cancer Liver Metastases#885657ClinicalTrials.gov
• A Study of Combination Therapy in Patients With Resectable Liver Cancer#899607ClinicalTrials.gov
• Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases#903841ClinicalTrials.gov
• The Role of Tumor-associated Macrophages in Colorectal Liver Metastases#387143ClinicalTrials.gov
• Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer#887910ClinicalTrials.gov
• Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies#812123ClinicalTrials.gov